TY - JOUR
T1 - Systematic review and meta-analysis of randomized, controlled trials on the effects of soy and soy products supplementation on serum adiponectin levels
AU - Mahmudiono, Trias
AU - Khaydarov, Nodirjon Kadirovich
AU - Jasim, Saade Abdalkareem
AU - Hammid, Ali Thaeer
AU - Failoc-Rojas, Virgilio E.
AU - Shalaby, Mohammed Nader
AU - Jannat, Behrooz
AU - Nouri, Mehran
AU - Fadel, Abdulmnannan
N1 - Funding Information:
None.
Publisher Copyright:
© 2022 Diabetes India
PY - 2022/7
Y1 - 2022/7
N2 - Background and aims: Our aim in this meta-analysis was to determine the effect of soy and soy product supplementation on serum adiponectin levels. Method: A systematic search was conducted using Medline (PubMed and Web of Science), Scopus, and Cochrane Library for eligible trials up to August 2020. A random-effects model was used to pool calculated effect sizes. Results: Seven trials were included in the overall analysis. Our analysis showed that soy and soy product supplementation did not significantly affect adiponectin concentrations (WMD = −0.77 μg/ml, 95% CI: −0.61, 2.15, P = 0.27) in comparison with a placebo. The between-study heterogeneity was high (I2: 68.2%, P = 0.004). Subgroup analysis, based on participants’ health status and duration of the supplementation, could not detect the potential source of the observed heterogeneity. In addition, subgroup analysis showed that the effect was not statistically significant in all subgroups. Conclusion: Overall, soy and soy product supplementation did not change the circulatory adiponectin levels. In addition, the results were not affected by the participant's health status and duration of supplementation. However, further studies are needed to confirm the present results.
AB - Background and aims: Our aim in this meta-analysis was to determine the effect of soy and soy product supplementation on serum adiponectin levels. Method: A systematic search was conducted using Medline (PubMed and Web of Science), Scopus, and Cochrane Library for eligible trials up to August 2020. A random-effects model was used to pool calculated effect sizes. Results: Seven trials were included in the overall analysis. Our analysis showed that soy and soy product supplementation did not significantly affect adiponectin concentrations (WMD = −0.77 μg/ml, 95% CI: −0.61, 2.15, P = 0.27) in comparison with a placebo. The between-study heterogeneity was high (I2: 68.2%, P = 0.004). Subgroup analysis, based on participants’ health status and duration of the supplementation, could not detect the potential source of the observed heterogeneity. In addition, subgroup analysis showed that the effect was not statistically significant in all subgroups. Conclusion: Overall, soy and soy product supplementation did not change the circulatory adiponectin levels. In addition, the results were not affected by the participant's health status and duration of supplementation. However, further studies are needed to confirm the present results.
KW - Adipokines
KW - Adiponectin
KW - Meta-analysis
KW - Soy
KW - Systematic review
UR - http://www.scopus.com/inward/record.url?scp=85133720873&partnerID=8YFLogxK
U2 - 10.1016/j.dsx.2022.102558
DO - 10.1016/j.dsx.2022.102558
M3 - Review article
AN - SCOPUS:85133720873
SN - 1871-4021
VL - 16
JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews
JF - Diabetes and Metabolic Syndrome: Clinical Research and Reviews
IS - 7
M1 - 102558
ER -